Announcement on Convening the Third Quarter 2025 Results Briefing Meeting
Securities code: 688136 Securities abbreviation: Sinovac Pharmaceutical Announcement number: 2025-092
Sinovac Biopharmaceutical Co., Ltd.
Announcement on Convening the Third Quarter 2025 Results Briefing
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Meeting time: November 17, 2025 (Monday) 10:00-11:00 Meeting location: Shanghai Stock Exchange SSE Roadshow Center (Website: https://roadshow.sseinfo.com/)
Meeting method: Shanghai Securities Roadshow Center online interaction
Investors can log in to the homepage of the SSE Roadshow Center website before 16:00 on November 14, 2025 (Friday) and click on the "Pre-Solicitation for Questions" column or ask questions through the company's email address [email protected]. The company will answer questions of common concern to investors at the briefing.
Sinovac Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has released the company's 2025 third quarter report on October 30, 2025. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's 2025 third quarter operating results and financial status, the company plans to hold the 2025 2025 Report on November 17, 2025 (Monday) from 10:00-11:00 The third quarter results briefing will be held to discuss issues of concern to investors.
1. Type of briefing session
This investor briefing will be held in an interactive online format. The company will interact and communicate with investors regarding the specific operating results and financial indicators in the third quarter of 2025, and answer questions of common concern to investors within the scope permitted by information disclosure.
2. Time and place of the briefing meeting
(1) Meeting time: November 17, 2025 (Monday) 10:00-11:00
(2) Meeting location: Shanghai Securities Roadshow Center
(3) Meeting method: SSE Roadshow Center online interaction
3. Participants
Director and General Manager: Zhao Yanqing
Director, Secretary of the Board, Financial Director: Wang Xiaoqin
(If there are special circumstances, participants may make adjustments)
4. How to participate as an investor
(1) Investors can log in to the SSE Roadshow Center (https://roadshow.sseinfo.com/) via the Internet from 10:00-11:00 on November 17, 2025 (Monday) to participate in this performance briefing online. The company will answer investors' questions in a timely manner.
(2) Investors can log in to the homepage of the SSE Roadshow Center website before 16:00 on November 14, 2025 (Friday), click on the "Ask a Question Pre-Solicitation" column (https://roadshow.sseinfo.com/preCallQa), and select this event according to the event time or via the company email [email protected] Ask the company questions and the company will answer questions of common concern to investors at the briefing.
5. Contact person and consultation method
Contact: Board Office
Tel: 0755-86967773
Email: [email protected]
6. Other matters
After the investor briefing is held, investors can check the status and main content of the investor briefing through the SSE Roadshow Center (https://roadshow.sseinfo.com/).
Announcement is hereby made.
Board of Directors of Sinovac Biopharmaceutical Co., Ltd.
November 11, 2025